Ahimsa Industries Ltd H1 FY26 — Sales Collapse to ₹0.05 Cr, PAT Bleeds ₹3.26 Cr, ROCE at -28.7%: A Manufacturing Company That Pressed Pause

1. At a Glance

₹13 crore market cap. Stock price hovering near ₹23.8. ROCE at a brutal -28.7%, ROE at -34.8%, and operating margin doing yoga poses humans can’t attempt (-94.4%). If this were a Bollywood script, the interval block would read: “Factory sold, machines exited, losses entered.”

Ahimsa Industries Ltd, once a full-stack PET preform and plastic engineering outfit, today looks like a company that walked into FY26 carrying a resignation letter for its own manufacturing business. Latest half-year numbers (H1 FY26) show sales shrinking to near-zero levels while losses remain very real, very alive, and very cash-burning.

This is not a “growth story paused temporarily due to macro headwinds.” This is a business model reset under financial stress, with asset sales, auditor exits, object clause amendments, and a pivot toward job-work and alternate activities. The stock market is not confused here — the price chart has already delivered its verdict with a 63% erosion over one year.

Yet, the company still exists, still files results, still has promoters holding 51%, and still attracts institutional names quietly entering the shareholding list. Which makes it interesting — not exciting, but interesting, like a paused crime documentary where the suspect hasn’t fled yet.

2. Introduction – From PET Powerhouse to Paperwork Factory

Ahimsa Industries was incorporated in 1996, back when PET preforms were the cool kids of packaging — lightweight, versatile, and replacing glass bottles faster than Indian households replaced landlines with mobile phones.

The company built a fairly integrated offering:

PET preforms under the Greenpet brand
Caps and closures
Plastic moulds
Turnkey beverage plant solutions
Engineering components
Project consultancy

In theory, this was a beautiful vertical integration story. In practice, by FY25–FY26, the factory gates started shutting, assets were sold, and manufacturing stopped.

The latest disclosures make it clear: Ahimsa has ceased manufacturing operations, sold land, building, plant, and machinery, and is now experimenting with a job-work model while amending its Memorandum of Association to allow entry into pharmaceutical-related activities.

This isn’t reinvention with a PowerPoint deck and capex plan. This is reinvention driven by survival instincts.

3. Business Model – WTF Do They Even Do Now?

Historically, Ahimsa Industries did five things:

PET Preforms
Manufacturing PET preforms used across water, CSD, edible oil, liquor, juice, pharma, and dairy packaging. Capacity stood at 7–8 lakh preforms per day, including exports to the USA.
Caps & Closures
Compression and injection-moulded caps for beverages and warm-fill applications.
Turnkey Beverage Projects
Supplying everything from machinery to raw materials for packaged water, soft drinks, juices, and dairy plants.
Engineering Components & Moulds
Injection moulds, blow moulds, die-casting moulds — the entire plastic tooling buffet.
Exports & Consultancy
Engineering projects and components supplied to Africa and other regions.

Now fast forward to FY25–FY26.

Manufacturing? Stopped.
Assets? Sold.
Revenue engine? Idling.
New business? Job work + future pharma ambition (on paper).

Right now, the company resembles a shell that once housed a full-fledged manufacturing organism. Whether the next organism thrives or suffocates depends entirely on execution — something the numbers are not yet willing to believe.

4. Financials Overview – Numbers That Didn’t Just Fall, They Slipped on Soap

Result Type Lock

The latest official disclosure clearly states Half Yearly Results.
So for EPS purposes:
Annualised EPS = Latest EPS × 2

Half-Yearly Performance Table (₹ crore)

Metric	Latest H1 FY26	H1 FY25	H2 FY25	YoY %	HoH %
Revenue	0.05	6.72	2.82	-99.3%	-98.2%
EBITDA	-0.22	-0.51	-2.49	Loss widened	Loss narrowed
PAT	-0.22	-0.92	-3.26	Loss reduced	Loss sharply reduced
EPS (₹)	-0.40	-1.68	-5.96	76.1%	93.3%

Annualised EPS (H1 FY26): -0.40 × 2 = -0.80

Yes, the losses have reduced quarter-on-quarter. But let’s not clap yet — revenues have practically evaporated. Cost cutting without income is not a turnaround; it’s a countdown timer.

5. Valuation Discussion –

To Read Full 16 Point